CUSIP: 72942A107
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,149,260
-
Share change
-
+242,190
-
Total reported value
-
$11,393,000
-
Price per share
-
$6.90
-
Number of holders
-
15
-
Value change
-
-$200,968
-
Number of buys
-
7
-
Number of sells
-
6
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2018
-
Previous quarter:
Q3 2017
Recent filing periods for CUSIP 72942A107:
Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q4 2017
As of 31 Dec 2017,
PLX PHARMA INC - COM (PLXPQ) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,149,260 shares.
The largest 10 holders included
Park West Asset Management LLC, Harel Insurance Investments & Financial Services Ltd., 683 Capital Management, LLC, BROWN ADVISORY INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, Heritage Way Advisors, LLC, and Fayez Sarofim & Co.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.